TruScient
Withdrawn
dibotermin alfa
MedicineVeterinaryWithdrawn
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
The marketing authorisation for TruScient has been withdrawn at the request of the marketing authorisation holder.
Osteoinductive agent for use in the treatment of long-bone fractures as an adjunct to standard surgical care using open fracture reduction in dogs.